Diclofenac metabolic pathway (WP2491)

Homo sapiens

CYP metabolism of the diclofenac drug (a NSAID), commonly used to treat pain and inflammatory diseases.

Authors

Egon Willighagen , Alex Pico , Denise Slenter , Friederike Ehrhart , and Eric Weitz

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Annotations

Pathway Ontology

phase I biotransformation pathway via cytochrome P450 xenobiotic metabolic pathway

Disease Ontology

disease

Participants

Label Type Compact URI Comment
diclofenac Metabolite pubchem.compound:3033
3'-Hydroxydiclofenac Metabolite pubchem.compound:112230
4'-hydroxydiclofenac Metabolite pubchem.compound:116545
5-hydroxydiclofenac Metabolite pubchem.compound:3052566
Metabolite Metabolite pubchem.compound:10065052
4',5-Dihydroxydiclofenac Metabolite pubchem.compound:3052567
CYP2C9 Protein uniprot:Q6IRV8
CYP2B6 Protein uniprot:P20813
CYP2C8 Protein uniprot:P10632
CYP2C18 Protein uniprot:P33260
CYP2C19 Protein uniprot:P33261
CYP2C9 Protein uniprot:Q6IRV8

References

  1. Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways. Bort R, Macé K, Boobis A, Gómez-Lechón MJ, Pfeifer A, Castell J. Biochem Pharmacol. 1999 Sep 1;58(5):787–96. PubMed Europe PMC Scholia